PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
Deferred Income Tax Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Deferred Income Tax
$55.9m
CAGR 3-Years
-26%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Deferred Income Tax
$2.7B
CAGR 3-Years
-9%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Deferred Income Tax
$907m
CAGR 3-Years
-41%
CAGR 5-Years
N/A
CAGR 10-Years
30%
Amgen Inc
NASDAQ:AMGN
Deferred Income Tax
$1.8B
CAGR 3-Years
N/A
CAGR 5-Years
18%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is PTC Therapeutics Inc's Deferred Income Tax?
Deferred Income Tax
55.9m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Deferred Income Tax amounts to 55.9m USD.

What is PTC Therapeutics Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
-14%

Over the last year, the Deferred Income Tax growth was 8%. The average annual Deferred Income Tax growth rates for PTC Therapeutics Inc have been -26% over the past three years , -14% over the past five years .

Back to Top